For individual immune checkpoints in the combined groups (II-VI), there were 22 (39%, PD-L1), 0 (0%, PD-1), 5 (9%, CTLA-4), and 6 (11%, IDO) cases who showed positive IHC staining in the tumor cells (Table 1). This evidence concerns the gene CTLA4 and neoplasm.